Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

Andre ABITBOL; May ABDEL-WAHAB; Alan LEWIN; Michael TRONER; Maria-Amelia RODRIGUES; Kara L HAMILTON-NELSON; Arnold MARKOE

doi:10.1016/S0360-3016(02)02816-X

$Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol$

Journal article

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

Andre ABITBOL, May ABDEL-WAHAB, Alan LEWIN, Michael TRONER, Maria-Amelia RODRIGUES, Kara L HAMILTON-NELSON and Arnold MARKOE

International journal of radiation oncology, biology, physics, Vol.53(4), pp.942-947

2002

DOI: https://doi.org/10.1016/S0360-3016(02)02816-X

PMID: 12095561

Abstract

Otorhinolaryngology. Stomatology

Ent and stomatology

Otorhinolaryngology (head neck, general aspects and miscellaneous)

Biological and medical sciences

Medical sciences

Diseases of the upper aerodigestive tract

Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)

Tumors

Metrics

23 Record Views

18 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.179 Oncology; 1.179.377 Head And Neck Cancer
Web Of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol
Creators: Andre ABITBOL - Department of Radiation Oncology, Baptist Hospital, Miami, FL, United States
May ABDEL-WAHAB - Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States
Alan LEWIN - Department of Radiation Oncology, Baptist Hospital, Miami, FL, United States
Michael TRONER - Department of Medical Oncology, Baptist Hospital, Miami, FL, United States
Maria-Amelia RODRIGUES - Department of Radiation Oncology, Baptist Hospital, Miami, FL, United States
Kara L HAMILTON-NELSON - Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States
Arnold MARKOE - Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States
Publication Details: International journal of radiation oncology, biology, physics, Vol.53(4), pp.942-947
Publisher: Elsevier; New York, NY
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
PMID: 12095561
Record Identifier: 991031576196202976